Top

Published in:

01-12-2018 | Case Report

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection

Authors: Lena M. Biehl, Rebeca Cruz Aguilar, Fedja Farowski, Werner Hahn, Angela Nowag, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild

Published in: Infection | Issue 6/2018

Abstract

Purpose

We report on a kidney transplant recipient treated with fecal microbiota transplantation (FMT) for recurrent urinary tract infections.

Methods

FMT was administered via frozen capsulized microbiota. Before and after FMT, urinary, fecal and vaginal microbiota compositions were analyzed.

Results

The patient remained without symptoms after FMT.

Conclusions

Underlying mechanisms of action need to be addressed in depth by future research.

Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–68.CrossRef

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84. https://doi.org/10.1038/nrmicro3432.CrossRefPubMedPubMedCentral

Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52:1212–7. https://doi.org/10.1093/cid/cir183.CrossRefPubMedPubMedCentral

Sundén F, Håkansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010;184:179–85. https://doi.org/10.1016/j.juro.2010.03.024.CrossRefPubMed

Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal microbiota transplantation for recurrent clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis. 2017;65:1745–7. https://doi.org/10.1093/cid/cix618.CrossRefPubMed

Illumina. 16S Sample Preparation Guide. Illumina. 2016. http://www.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/16s/16s-metagenomic-library-prep-guide-15044223-b.pdf. Accessed 27 Sept 2016.

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581. https://doi.org/10.1038/nmeth.3869. https://www.nature.com/articles/nmeth.3869#supplementary-information.CrossRef

R Core Team. R: a language and environment for statistical computing. 3.2.5 ed. Vienna: R Foundation for Statistical Computing; 2016.

Tacke D, Wisplinghoff H, Kretzschmar A, Farowski F, Koehler P, Herweg J, et al. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe. Clin Microbiol Infect. 2015;21:e82–4. https://doi.org/10.1016/j.cmi.2015.06.027.CrossRefPubMed

10.

Schreiber HL, Conover MS, Chou WC, Hibbing ME, Manson AL, Dodson KW, et al. Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections. Sci Transl Med. 2017. https://doi.org/10.1126/scitranslmed.aaf1283.CrossRefPubMedPubMedCentral

11.

Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract—a role beyond infection. Nat Rev Urol. 2015;12:81–90. https://doi.org/10.1038/nrurol.2014.361.CrossRefPubMed

12.

den Heijer CD, Beerepoot MA, Prins JM, Geerlings SE, Stobberingh EE. Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections. PLoS One. 2012;7:e49909. https://doi.org/10.1371/journal.pone.0049909.CrossRef

Title: Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection
Authors: Lena M. Biehl
Rebeca Cruz Aguilar
Fedja Farowski
Werner Hahn
Angela Nowag
Hilmar Wisplinghoff
Maria J. G. T. Vehreschild
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 6/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-018-1190-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Correction to: Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series

Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure

Dihydroartemisinin–piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia

Diagnosis of nontuberculous mycobacterial disease in the era of surveillance chest CT scans

Overuse of antimicrobials and over-hospitalization in an adult measles cluster in the Florence area during the ongoing Italian outbreak

Essentials in Candida bloodstream infection

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page